博瑞医药：终止2024年度向特定对象发行A股股票事项并撤回申请文件

Core Viewpoint - 博瑞医药 has decided to terminate the issuance of A-shares to specific investors for the year 2024, citing current market conditions and the company's development plans as key factors [1] Group 1 - The decision was made after thorough communication and careful consideration with relevant parties [1] - The company has withdrawn its application documents related to the A-share issuance [1] - This termination will not have a significant impact on the company's normal operations and sustainable development [1]